In lesional ME (ME19, 13, 8), genes associated with susceptibility to MS (HLA-DPB1, (104)), risk of developing progressive MS (NR1H3, (105)), and circulating markers that discriminate chronic active versus inactive MS lesions (CHIT1, (106)), are regionally elevated. This evidence concerns the gene HLA-DPB1 and myeloid sarcoma.